NCT06996093 2025-05-30Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 InhibitorFudan UniversityPhase 3 Not yet recruiting2,508 enrolled